Warning: This security is no longer trading.
Bristol-Myers Squibb Completes Acquisition Of Celgene
Celgene Corporation (CELG): Price and Financial Metrics
CELG Price/Volume Stats
| Current price | $108.24 | 52-week high | $110.70 |
| Prev. close | $108.13 | 52-week low | $58.59 |
| Day low | $107.27 | Volume | 191,230,496 |
| Day high | $108.59 | Avg. volume | 7,709,665 |
| 50-day MA | $103.23 | Dividend yield | N/A |
| 200-day MA | $95.60 | Market Cap | 77.04B |
CELG Stock Price Chart Interactive Chart >
Celgene Corporation (CELG) Company Bio
Celgene is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company was founded in 1980 and is based in Summit, New Jersey.
CELG Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 14.88% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | 0.00% |
Loading social stream, please wait...